Global Autoinjectors Market to reach USD 5.6 billion by 2027

Global Autoinjectors Market Size study, by Type (Disposable Autoinjectors, Reusable Autoinjectors), by Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Others), by End-User (Home Care Settings, Hospitals & Clinics) and Regional Forecasts 2020-2027
Product Code:  ALATST_57834416
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Autoinjectors Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Autoinjectors Market, by Type, 2018-2027 (USD Billion)
1.2.3.	Autoinjectors Market, by Application, 2018-2027 (USD Billion)
1.2.4.	Autoinjectors Market, by End-User, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Autoinjectors Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Autoinjectors Market Dynamics	
3.1.	Autoinjectors Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Autoinjectors Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Autoinjectors Market, by Type 
5.1.	Market Snapshot 
5.2.	Global Autoinjectors Market by Type, Performance - Potential Analysis
5.3.	Global Autoinjectors Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4.	Autoinjectors Market, Sub Segment Analysis
5.4.1.	Disposable Autoinjectors 
5.4.2.	Reusable Autoinjectors
Chapter 6.	Global Autoinjectors Market, by Application          
6.1.	Market Snapshot 
6.2.	Global Autoinjectors Market by Application, Performance - Potential Analysis
6.3.	Global Autoinjectors Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4.	Autoinjectors Market, Sub Segment Analysis
6.4.1.	Rheumatoid Arthritis
6.4.2.	Anaphylaxis
6.4.3.	Multiple Sclerosis
6.4.4.	Others
Chapter 7.	Global Autoinjectors Market, by End-User
7.1.	Market Snapshot 
7.2.	Global Autoinjectors Market by End-User - Potential Analysis
7.3.	Global Autoinjectors Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4.	Autoinjectors Market, Sub Segment Analysis
7.4.1.	Home Care Settings
7.4.2.	Hospitals & Clinics
Chapter 8.	Global Autoinjectors Market, Regional Analysis
8.1.	Autoinjectors Market, Regional Market Snapshot 
8.2.	North America Autoinjectors Market 
8.2.1.	U.S. Autoinjectors Market
8.2.1.1.	Type breakdown estimates & forecasts, 2017-2027
8.2.1.2.	Application breakdown estimates & forecasts, 2017-2027
8.2.1.3.	End-User breakdown estimates & forecasts, 2017-2027
8.2.2.	Canada Autoinjectors Market
8.3.	Europe Autoinjectors Market Snapshot
8.3.1.	U.K. Autoinjectors Market 
8.3.2.	Germany Autoinjectors Market
8.3.3.	France Autoinjectors Market
8.3.4.	Spain Autoinjectors Market
8.3.5.	Italy Autoinjectors Market
8.3.6.	Rest of Europe Autoinjectors Market
8.4.	Asia-Pacific Autoinjectors Market Snapshot
8.4.1.	China Autoinjectors Market 
8.4.2.	India Autoinjectors Market 
8.4.3.	Japan Autoinjectors Market
8.4.4.	Australia Autoinjectors Market
8.4.5.	South Korea Autoinjectors Market
8.4.6.	Rest of Asia Pacific Autoinjectors Market
8.5.	Latin America Autoinjectors Market Snapshot
8.5.1.	Brazil Autoinjectors Market
8.5.2.	Mexico Autoinjectors Market
8.6.	Rest of The World Autoinjectors Market
Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	Amgen Inc.
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject to Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	Antares Pharma, Inc.
9.2.3.	Becton Dickinson and Company
9.2.4.	Eli Lilly and Company
9.2.5.	Johnson and Johnson
9.2.6.	Mylan N.V.
9.2.7.	Novartis AG
9.2.8.	SHL Medical
9.2.9.	Teva Pharmaceutical Industries Ltd
9.2.10.	Ypsomed AG
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Autoinjectors Market is valued approximately at USD 1.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 18% over the forecast period 2020-2027. An autoinjector is a type of medical device intended to provide a dose of a specific drug. It has a syringe-like structure with a spring-charged needle allowing a pre-charged dosage of drugs. Autoinjectors are extensively utilized for epinephrine self-administration (to inhibit the prevalence of anaphylaxis); by migraine patients (for instant pain relief); or in an emergency and medical treatments. Auto-injectors are increasingly preferred over traditional devices since they facilitate advanced and effective drug delivery as well as new formulations. Further, they are often used to provide a variety of benefits, such as reducing needle-associated phobia syndrome, lowering hazards of needle stuck mishaps, ensuring dosage quality stability, and also helps to increase effectiveness, thereby accelerating the market growth worldwide. Moreover, the rise in prevalence of multiple sclerosis and anaphylaxis, favorable reimbursements and government support, and the high availability of generic versions of autoinjectors are the few factors responsible for the CAGR of the market during the forecast period. According to the study of the National Multiple Sclerosis Society in 2017, nearly 1 million adults (up to 913,925) were living with multiple sclerosis in the United States. This estimation is more than double the previously reported numbers from a national study since 1975. Also, as of March 2020, over 2.3 million people get diagnosed of multiple sclerosis around the world. This, in turn, is expected to strengthen the demand for Autoinjectors, thereby contributing to the market growth across the globe. However, the availability of substitute products such as general injections and oral tablets is one of the major factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Autoinjectors market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the government support and rising demand for high-quality medical products, along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in incidences of autoimmune and chronic diseases coupled with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Autoinjectors market across the Asia-Pacific region.

Major market player included in this report are:
Amgen Inc.
Antares Pharma, Inc.
Becton Dickinson and Company
Eli Lilly and Company
Johnson and Johnson
Mylan N.V.
Novartis AG
SHL Medical
Teva Pharmaceutical Industries Ltd
Ypsomed AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Disposable Autoinjectors
Reusable Autoinjectors

By Application:
Rheumatoid Arthritis
Anaphylaxis
Multiple Sclerosis
Others

By End-User:
Home Care Settings
Hospitals & Clinics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Autoinjectors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…